Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Accepts healthy volunteers

Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE

ClinicalTrials.gov ID: NCT04293458

Public ClinicalTrials.gov record NCT04293458. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 1:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Single-Arm Study of the Efficacy of EsoGuard(TM) on Samples Collected Using EsoCheck(TM) Versus Esophagogastroduodenoscopy for the Diagnosis of Barrett's Esophagus in an At-Risk Screening Population

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will assess the performance of the combined system, i.e., the use of the EsoGuard assay on cells collected using the EsoCheck 510(k) cleared device, to detect Barrett's Esophagus, with and without dysplasia, and/or Esophageal Adenocarcinoma, in individuals deemed to be at high risk for these conditions (i.e., screening) per ACG guidelines.

Study identification

NCT ID
NCT04293458
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Lucid Diagnostics, Inc.
Industry
Enrollment
145 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
Male
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2020 (Actual)
Primary completion
Aug 22, 2022 (Actual)
Completion
Aug 22, 2022 (Actual)
Last update posted
Jan 25, 2023

2020 – 2022

United States locations

U.S. sites
24
U.S. states
19
U.S. cities
23
Facility City State ZIP Site status
Lucid Investigative Site Orange California 92868 —
Lucid Investigative Site Englewood Colorado 80113 —
Lucid Investigative Site Naples Florida 34102 —
Lucid Investigative Site Palm Harbor Florida 34684 —
Lucid Investigative Site Macon Georgia 31201 —
Lucid Investigative Site Idaho Falls Idaho 83404 —
Lucid Investigative Site Rockford Illinois 61107 —
Lucid Investigative Site New Orleans Louisiana 70112 —
Lucid Investigative Site Shreveport Louisiana 71105 —
Lucid Investigative Site Wyoming Michigan 49519 —
Lucid Investigative Site Flowood Mississippi 39232 —
Lucid Investigative Site Omaha Nebraska 68124 —
Lucid Investigative Site New York New York 10016 —
Lucid Investigative Site Rochester New York 14620 —
Lucid Investigative Site Chapel Hill North Carolina 27599 —
Lucid Investigative Site Oklahoma City Oklahoma 73102 —
Lucid Investigative Site Philadelphia Pennsylvania 19107 —
Lucid Investigative Site Greenville South Carolina 29615 —
Lucid Investigative Site Knoxville Tennessee 37909 —
Lucid Investigative Site Nashville Tennessee 37212 —
Lucid Investigative Site Houston Texas 77030 —
Lucid Investigative Site Salt Lake City Utah 84132 —
Lucid Investigative Site Richmond Virginia 23249 —
Lucid Investigative Site Richmond Virginia 23298 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04293458, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 25, 2023 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04293458 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →